Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 26, Issue 1, 2014, Pages 57-63

  Dobkin, Roseanne D ^a   Tröster, Alexander I ^a   Rubino, Jade Tiu ^a   Allen, Lesley A ^a   Gara, Michael A ^a   Mark, Margery H ^a   Menza, Matthew ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MOOD; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VERBAL MEMORY; VERY ELDERLY; WORKING MEMORY;

ADULT; AGED; AGED, 80 AND OVER; COGNITIVE THERAPY; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; MODELS, STATISTICAL; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84901450992     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12120381     Document Type: Article

References (40)

1. Reijnders JS, Ehrt U, Weber WEJ, et al: A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23:183-189, quiz 313
2. Starkstein SE, Mayberg HS, Leiguarda R, et al: A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55:377-382
3. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al: Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008; 23:1420-1427
4. Ravina B, Camicioli R, Como PG, et al: The impact of depressive symptoms in early Parkinson disease. Neurology 2007; 69:342-347
5. Carter JH, Stewart BJ, Lyons KS, et al: Do motor and non-motor symptoms in PD patients predict caregiver strain and depression? Mov Disord 2008; 23:1211-1216
6. Marder K, Tang MX, Cote L, et al: The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995; 52:695-701
7. Riedel O, Heuser I, Klotsche J; GEPAD Study Group, et al: Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study. J Geriatr Psychiatry Neurol 2010; 23:27-34
8. Fernandez HH, See RH, Gary MF, et al: Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance. J Geriatr Psychiatry Neurol 2009; 22:223-227
9. Kummer A, Harsányi E, Dias FM, et al: Depression impairs executive functioning in Parkinson disease patients with low educational level. Cogn Behav Neurol 2009; 22:167-172
10. Kuzis G, Sabe L, Tiberti C, et al: Cognitive functions in major depression and Parkinson disease. Arch Neurol 1997; 54:982-986
11. Santangelo G, Vitale C, Trojano L, et al: Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. J Neurol 2009; 256:632-638
12. Klepac N, Trkulja V: Education effect on depression and quality of life in nondemented Parkinson's disease patients. J Neuropsychiatry Clin Neurosci 2009; 21:314-322
13. Butterfield LC, Cimino CR, Oelke LE, et al: The independent influence of apathy and depression on cognitive functioning in Parkinson's disease. Neuropsychology 2010; 24:721-730
14. Costa A, Peppe A, Carlesimo GA, et al: Major and minor depression in Parkinson's disease: a neuropsychological investigation. Eur J Neurol 2006; 13:972-980
15. Klepac N, Hajnsek S, Trkulja V: Cognitive performance in nondemented, nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms. J Geriatr Psychiatry Neurol 2010; 23:15-26
16. Stefanova E, Potrebic A, Ziropadja L, et al: Depression predicts the pattern of cognitive impairment in early Parkinson's disease. J Neurol Sci 2006; 248:131-137
17. Fregni F, Santos CM, Myczkowski ML, et al: Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75:1171-1174
18. Weintraub D, Mavandadi S, Mamikonyan E, et al: Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010; 75:448-455
19. Boggio PS, Fregni F, Bermpohl F, et al: Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord 2005; 20:1178-1184
20. Devos D, Dujardin K, Poirot I, et al: Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebocontrolled study. Mov Disord 2008; 23:850-857
21. Menza M, Dobkin RD, Marin H, et al: A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 2009; 72:886-892
22. Rektorová I: Effects of dopamine agonists on neuropsychiatric symptoms of Parkinson's disease. Neurodegener Dis 2010; 7:206-209
23. Dobkin RD, Menza M, Bienfait KL, et al: The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 2010; 22:188-195
24. Weintraub D, Taraborelli D, Morales KH, et al: Escitalopram for major depression in Parkinson's disease: an open-label, flexibledosage study. J Neuropsychiatry Clin Neurosci 2006; 18:377-383
25. Dobkin RD, Menza M, Allen LA, et al: Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry 2011; 168:1066-1074
26. Ryder KA, Gontkovsky ST, McSwan KL, et al: Cognitive function in Parkinson's disease: association with anxiety but not depression. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2002; 9:77-84
27. Gelb DJ, Oliver E, Gilman S: Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56:33-39
28. Guy W: ECDEU Assessment Manual for Psychopharmacology. Washington, DC, U.S. Department of Health, Education, and Welfare, 1976
29. Mattis S: Dementia Rating Scale. Odessa, FL, Psychological Assessment Resources, 1988
30. Benedict RHB, Schretlen D, Groninger L, et al: Hopkins Verbal Learning Test-Revised: normative data and analysis of interform and test-retest reliability. Clin Neuropsychol 1998; 12:43-55
31. Delis D, Kaplan E, Kramer J: Delis-Kaplan Executive Function System. San Antonio, TX, Psychological Corporation, 2001
32. Wechsler D: Wechsler Memory Scale, 3rd Edition. San Antonio, TX, Psychological Corporation, 1997
33. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
34. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
35. Fahn S, Elton RL, members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale, in Recent Developments in Parkinson's Disease. Edited by Fahn S, Marsden CD, Calne DB, et al. Florham Park, NJ, Macmillan Health Care Information, 1987, pp 53-64
36. Black KJ, Hershey T, Hartlein JM, et al: Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology 2005; 30: 590-601
37. Ring HA, Bench CJ, Trimble MR, et al: Depression in Parkinson's disease: a positron emission study. Br J Psychiatry 1994; 165:333-339
38. Calleo J, Burrows C, Levin H et al. M. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinson Dis 2012; Article ID 512892, 6 pages; doi:10.1155/2012/512892
39. Teri L, Gallagher-Thompson D: Cognitive-behavioral interventions for treatment of depression in Alzheimer's patients. Gerontologist 1991; 31:413-416
40. Houle J, Villaggi B, Beaulieu MD: Treatment preferences in patients with first episode major depression. J Affect Disord 2013; 147:94-100; available at doi: 10.1016/j.jad.2012.10.016